BIORDI, ASSUNTA LEDA
 Distribuzione geografica
Continente #
NA - Nord America 1.479
EU - Europa 976
AS - Asia 663
SA - Sud America 87
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.218
Nazione #
US - Stati Uniti d'America 1.473
IE - Irlanda 263
SG - Singapore 225
CN - Cina 190
SE - Svezia 136
TR - Turchia 134
DE - Germania 111
RU - Federazione Russa 101
IT - Italia 91
GB - Regno Unito 86
HK - Hong Kong 83
BR - Brasile 82
UA - Ucraina 79
FI - Finlandia 46
FR - Francia 31
BE - Belgio 13
IN - India 9
VN - Vietnam 6
CZ - Repubblica Ceca 5
IQ - Iraq 4
CA - Canada 3
EG - Egitto 3
EU - Europa 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
IL - Israele 2
PK - Pakistan 2
RS - Serbia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
GT - Guatemala 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.218
Città #
Jacksonville 303
Dublin 262
Chandler 261
Singapore 114
Boardman 99
Hong Kong 83
Ann Arbor 81
Santa Clara 80
Wilmington 60
Izmir 58
San Mateo 57
Nanjing 52
Lawrence 38
Princeton 38
Woodbridge 31
Ashburn 30
Moscow 29
New York 29
Milan 20
Nanchang 20
Los Angeles 16
Mountain View 16
Seattle 16
Shenyang 16
Beijing 14
Des Moines 14
Munich 14
Brussels 13
Falls Church 12
Helsinki 12
Kunming 12
L'aquila 12
Verona 12
Bremen 10
Jiaxing 10
Tianjin 10
Dallas 8
Belo Horizonte 7
Jinan 7
Changsha 6
Dong Ket 6
Grafing 6
Zhengzhou 6
Guangzhou 5
Hebei 5
Ningbo 5
Pune 5
Ancona 4
Brno 4
Curitiba 4
Mosciano Sant'Angelo 4
Philadelphia 4
Baghdad 3
Cairo 3
Clifton 3
Dearborn 3
Frankfurt am Main 3
Fremont 3
L’Aquila 3
Napoli 3
Phoenix 3
Sulmona 3
São Paulo 3
Tappahannock 3
Abu Dhabi 2
Auburn Hills 2
Belgrade 2
Brasília 2
Cedar Knolls 2
Duque de Caxias 2
Garland 2
Guardiagrele 2
Houston 2
Karaikal 2
Lanciano 2
Norwalk 2
Rio de Janeiro 2
Shanghai 2
Taizhou 2
The Dalles 2
Toronto 2
Aachen 1
Amsterdam 1
Antakya 1
Aracaju 1
Araucária 1
Araçatuba 1
Arenápolis 1
Asunción 1
Avellino 1
Bauru 1
Bellante 1
Berlin 1
Bishkek 1
Bologna 1
Brasópolis 1
Brest 1
Buffalo 1
Büdelsdorf 1
Campinas 1
Totale 2.129
Nome #
ANTIANDROGENS AND 5-ALPHA REDUCTASE INHIBITION OF THE PROLIFERATION RATE IN PC3 AND DU145 HUMAN PROSTATIC-CANCER CELL-LINES 113
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 107
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 106
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 105
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 103
Biomolecular characterization of human glioblastoma cells in primary cultures: differentiating and antiangiogenic effects of natural and synthetic PPARgamma agonists 102
Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas 96
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 94
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 94
Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities 91
Imipenem concentrations in human prostatic tissue: Clinical implications 90
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. 90
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 88
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 87
The role of CXCR2 activity in the contact hypersensitivity response in mice 86
Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage 85
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 84
ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PROSTATIC-CARCINOMA CELL STRAIN OBTAINED FROM EXFOLIATED TUMOR-CELLS AFTER PROSTATIC MASSAGE 83
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 83
Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis 83
New mutations and protein variants of NBSI are identified in cancer cell lines 82
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 81
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography 79
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice 79
FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO 77
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines 76
HORMONE TREATMENT PROMOTES CASTRATION-RESISTANT PHENOTYPE BY INCREASING PI3K/AKT ACTIVITY IN PROSTATE CANCER MODELS. PRECLINICAL DATA ON COMBINED PHOSPHATIDYLINOSITOL-3-KINASE/MTOR INHIBITION WITH ENDOCRINE THERAPY FOR ANDROGEN RECEPTOR-POSITIVE PROSTATE CANCER CELLS 75
Statistical modelling of serum parameters for the prediction of histological liver damage in chronic hepatitis C 74
INCREASED RADIOSENSITIVITY AFTER ANDROGENIC MANIPULATION IN PROSTATE CANCER CELL MODELS 72
Prevention of AIDS and other infectious diseases among dental professionals: A survey in two Italian regions 72
Modificazioni strutturali della parete vaginale in donne affette da prolasso genitale (POP) 71
Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2 67
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 67
R- and s-isomers of nonsteroidal anti-inflammatory drugs differentially regulate cytokine production 67
Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures 65
Erk-dependent cytosolic phospholipase A2 activity is induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells 64
DIAGNOSI PRECOCE DI CARCINOMA PROSTATICO MEDIANTE COLTURE DI CELLULE DI SFALDAMENTO 62
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 62
IL-2 activated rat NK cells express inducible nitric oxide sinthase which contributes to the cytotoxic function IFN-gamma production 59
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 40
Targeted molecular therapy in glioblastoma 14
Totale 3.275
Categoria #
all - tutte 13.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 0 0 0 0 0 13 5 47
2020/2021348 11 40 1 45 38 17 45 0 41 19 68 23
2021/2022311 19 27 55 20 12 17 5 16 13 41 18 68
2022/2023786 53 51 11 77 81 90 0 45 352 0 18 8
2023/2024176 31 11 4 27 16 36 2 21 0 7 8 13
2024/2025703 10 16 67 61 106 77 138 50 170 8 0 0
Totale 3.275